Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Cilansetron – New Treatment for IBS

Drug (Brand / Generic)

Cilansetron

Company / Licensee

Solvay Pharmaceuticals

Therapy Class

5-HT3 antagonist

Product Description

Blocks 5-HT3 receptors on sensory neurones in the GI tract

Current indication

Diarrhoea-predominant IBS

Market Sector

GI

Development Status

Discontinued
Expand

Go Top